Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines against “Swine” Influenza A (H1N1)
Posted on 30 June 2009 by FLU
SAN DIEGO–(BUSINESS WIRE)–Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today it has established a new collaboration with the National
Go here to read the rest:
Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines against “Swine” Influenza A (H1N1)
Related posts:
- Inovio Biomedical, National Microbiology Laboratory, And University Of Pennsylvania To Evaluate Candidate DNA Vaccines Against "Swine" Influenza A Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA...
- Inovio assesses vaccine against swine flu – Drugs.com MedNews Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to...
- Inovio assesses vaccine against swine flu Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to...
- Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader...
- Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex:INO), a leader in...
Related posts brought to you by Yet Another Related Posts Plugin.
Tags | announced-today, article, h1n1, latest, san, swine flu, swine flu symptoms, the-world, united, world
